Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Androgens | 6 | 2021 | 267 | 3.03 | Why? |
Alopecia | 9 | 2020 | 351 | 2.51 | Why? |
Receptors, Androgen | 7 | 2021 | 212 | 2.33 | Why? |
Tattooing | 3 | 2018 | 27 | 2.11 | Why? |
Syringes | 3 | 2018 | 70 | 2.10 | Why? |
Androgen Antagonists | 6 | 2021 | 404 | 1.90 | Why? |
Chemexfoliation | 3 | 2018 | 10 | 1.71 | Why? |
Croton Oil | 5 | 2019 | 5 | 1.51 | Why? |
Silicone Oils | 2 | 2018 | 7 | 1.51 | Why? |
Lubricants | 2 | 2018 | 55 | 1.43 | Why? |
Alopecia Areata | 2 | 2021 | 140 | 1.35 | Why? |
Diterpenes | 2 | 2019 | 157 | 1.35 | Why? |
Fluorouracil | 2 | 2018 | 169 | 1.34 | Why? |
Dermatologic Agents | 3 | 2018 | 489 | 1.02 | Why? |
Dermoscopy | 2 | 2017 | 346 | 0.97 | Why? |
Phenol | 2 | 2018 | 24 | 0.95 | Why? |
Oxandrolone | 1 | 2021 | 4 | 0.92 | Why? |
Thiohydantoins | 1 | 2021 | 5 | 0.92 | Why? |
Anabolic Agents | 1 | 2021 | 49 | 0.88 | Why? |
Hypopigmentation | 2 | 2018 | 28 | 0.87 | Why? |
Hyperandrogenism | 1 | 2020 | 36 | 0.87 | Why? |
Oxazoles | 1 | 2021 | 75 | 0.86 | Why? |
Spironolactone | 2 | 2020 | 114 | 0.83 | Why? |
Croton | 1 | 2019 | 4 | 0.80 | Why? |
Hypogonadism | 1 | 2021 | 196 | 0.80 | Why? |
Phenols | 2 | 2018 | 226 | 0.76 | Why? |
Keratosis, Actinic | 1 | 2019 | 54 | 0.74 | Why? |
Mineralocorticoid Receptor Antagonists | 1 | 2020 | 203 | 0.73 | Why? |
Keratolytic Agents | 1 | 2017 | 16 | 0.72 | Why? |
Ink | 1 | 2017 | 7 | 0.72 | Why? |
Lip | 1 | 2018 | 61 | 0.72 | Why? |
Triamcinolone Acetonide | 1 | 2017 | 10 | 0.72 | Why? |
Drug Packaging | 1 | 2017 | 33 | 0.71 | Why? |
Triamcinolone | 1 | 2017 | 24 | 0.71 | Why? |
Simuliidae | 1 | 2017 | 8 | 0.70 | Why? |
Lichenoid Eruptions | 1 | 2017 | 22 | 0.70 | Why? |
Agricultural Workers' Diseases | 1 | 2017 | 16 | 0.70 | Why? |
Dermal Fillers | 1 | 2017 | 41 | 0.68 | Why? |
Angiomatosis | 1 | 2017 | 12 | 0.68 | Why? |
Polyesters | 1 | 2017 | 94 | 0.68 | Why? |
Scurvy | 1 | 2017 | 10 | 0.68 | Why? |
Thinking | 1 | 2018 | 105 | 0.65 | Why? |
Insect Bites and Stings | 1 | 2017 | 63 | 0.65 | Why? |
Injection Site Reaction | 1 | 2017 | 124 | 0.64 | Why? |
Stevens-Johnson Syndrome | 1 | 2019 | 129 | 0.64 | Why? |
Skin | 2 | 2019 | 2096 | 0.64 | Why? |
Smoke | 1 | 2018 | 349 | 0.56 | Why? |
Pemphigus | 1 | 2017 | 163 | 0.54 | Why? |
Inhalation Exposure | 1 | 2018 | 405 | 0.52 | Why? |
Janus Kinase Inhibitors | 1 | 2018 | 682 | 0.49 | Why? |
Acquired Immunodeficiency Syndrome | 1 | 2019 | 533 | 0.47 | Why? |
Injections, Subcutaneous | 3 | 2018 | 647 | 0.45 | Why? |
Prostatic Neoplasms | 2 | 2021 | 1637 | 0.45 | Why? |
Occupational Exposure | 2 | 2018 | 4742 | 0.39 | Why? |
Hand Hygiene | 1 | 2020 | 1493 | 0.39 | Why? |
Skin Aging | 2 | 2018 | 55 | 0.35 | Why? |
Virus Internalization | 3 | 2020 | 7921 | 0.33 | Why? |
Severity of Illness Index | 6 | 2021 | 48226 | 0.31 | Why? |
Azithromycin | 1 | 2021 | 3943 | 0.30 | Why? |
Renin-Angiotensin System | 1 | 2020 | 3661 | 0.28 | Why? |
Electrocardiography | 1 | 2017 | 3957 | 0.25 | Why? |
Dermatology | 1 | 2018 | 1999 | 0.24 | Why? |
Humans | 43 | 2021 | 930598 | 0.23 | Why? |
Performance-Enhancing Substances | 1 | 2021 | 20 | 0.22 | Why? |
5-alpha Reductase Inhibitors | 1 | 2020 | 30 | 0.22 | Why? |
Enzyme Induction | 1 | 2020 | 89 | 0.22 | Why? |
Serine | 1 | 2020 | 90 | 0.21 | Why? |
Dietary Carbohydrates | 1 | 2021 | 64 | 0.21 | Why? |
CLOCK Proteins | 1 | 2020 | 24 | 0.21 | Why? |
Pneumonia, Viral | 11 | 2020 | 243684 | 0.20 | Why? |
Skin Diseases | 1 | 2017 | 2509 | 0.20 | Why? |
Serine Endopeptidases | 3 | 2020 | 4606 | 0.20 | Why? |
Chromosomes, Human, X | 1 | 2020 | 81 | 0.20 | Why? |
Hormone Replacement Therapy | 1 | 2021 | 146 | 0.20 | Why? |
Sclerosis | 1 | 2018 | 26 | 0.20 | Why? |
Male | 22 | 2021 | 367725 | 0.19 | Why? |
Work Schedule Tolerance | 1 | 2020 | 158 | 0.19 | Why? |
Betacoronavirus | 8 | 2020 | 204454 | 0.19 | Why? |
Forehead | 1 | 2018 | 48 | 0.19 | Why? |
Leprosy, Borderline | 1 | 2018 | 10 | 0.19 | Why? |
Skin Absorption | 1 | 2017 | 18 | 0.18 | Why? |
Genetic Loci | 1 | 2020 | 439 | 0.18 | Why? |
Melanocytes | 1 | 2018 | 44 | 0.18 | Why? |
Coronavirus Infections | 11 | 2020 | 253789 | 0.18 | Why? |
Energy Intake | 1 | 2021 | 323 | 0.18 | Why? |
Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.18 | Why? |
Injections, Intradermal | 1 | 2017 | 102 | 0.18 | Why? |
Botulinum Toxins | 1 | 2018 | 89 | 0.18 | Why? |
Dapsone | 1 | 2018 | 59 | 0.18 | Why? |
Adsorption | 1 | 2018 | 261 | 0.17 | Why? |
Mucous Membrane | 1 | 2020 | 305 | 0.17 | Why? |
Epidemiologic Studies | 1 | 2020 | 554 | 0.17 | Why? |
Pandemics | 14 | 2021 | 389249 | 0.17 | Why? |
Poisson Distribution | 1 | 2019 | 348 | 0.17 | Why? |
Leprostatic Agents | 1 | 2018 | 94 | 0.17 | Why? |
Cardiotonic Agents | 1 | 2020 | 418 | 0.17 | Why? |
Personal Protective Equipment | 2 | 2020 | 15978 | 0.16 | Why? |
Hydroxychloroquine | 1 | 2021 | 12447 | 0.16 | Why? |
Drug Hypersensitivity Syndrome | 1 | 2018 | 74 | 0.16 | Why? |
Carbon | 1 | 2018 | 269 | 0.16 | Why? |
Promoter Regions, Genetic | 1 | 2020 | 823 | 0.15 | Why? |
Healthy Lifestyle | 1 | 2021 | 447 | 0.15 | Why? |
Prognosis | 4 | 2021 | 32490 | 0.15 | Why? |
Statistics, Nonparametric | 1 | 2019 | 1008 | 0.15 | Why? |
Testosterone | 1 | 2021 | 596 | 0.15 | Why? |
Alleles | 1 | 2021 | 1557 | 0.14 | Why? |
Circadian Rhythm | 1 | 2020 | 607 | 0.14 | Why? |
Adult | 12 | 2021 | 244371 | 0.13 | Why? |
Transcription, Genetic | 1 | 2020 | 1326 | 0.13 | Why? |
Patient Acuity | 1 | 2020 | 1755 | 0.13 | Why? |
Sex Distribution | 1 | 2020 | 2083 | 0.12 | Why? |
Water | 1 | 2017 | 765 | 0.12 | Why? |
Spike Glycoprotein, Coronavirus | 2 | 2020 | 37182 | 0.12 | Why? |
Th17 Cells | 1 | 2018 | 657 | 0.12 | Why? |
Particle Size | 1 | 2017 | 1052 | 0.12 | Why? |
Peptides | 2 | 2021 | 2513 | 0.12 | Why? |
Primary Prevention | 1 | 2018 | 778 | 0.11 | Why? |
Risk Factors | 5 | 2021 | 71621 | 0.11 | Why? |
Drug Combinations | 1 | 2021 | 3852 | 0.11 | Why? |
Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
Clinical Trials as Topic | 2 | 2021 | 7330 | 0.10 | Why? |
Uncertainty | 1 | 2021 | 1888 | 0.10 | Why? |
Genetic Variation | 2 | 2020 | 3919 | 0.10 | Why? |
Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.09 | Why? |
Female | 10 | 2021 | 380317 | 0.09 | Why? |
Antimalarials | 1 | 2021 | 2505 | 0.09 | Why? |
Biopsy | 1 | 2017 | 2811 | 0.09 | Why? |
Diet | 1 | 2021 | 2052 | 0.09 | Why? |
Life Style | 1 | 2021 | 2708 | 0.09 | Why? |
Antiviral Agents | 1 | 2021 | 41703 | 0.09 | Why? |
Seasons | 1 | 2020 | 4071 | 0.08 | Why? |
Exanthema | 1 | 2017 | 1097 | 0.08 | Why? |
Disease Susceptibility | 1 | 2020 | 4002 | 0.08 | Why? |
Hypersensitivity | 1 | 2017 | 1137 | 0.08 | Why? |
Patient Admission | 2 | 2020 | 5250 | 0.08 | Why? |
Time Factors | 2 | 2021 | 31397 | 0.08 | Why? |
Blood Glucose | 1 | 2021 | 3642 | 0.08 | Why? |
ROC Curve | 1 | 2019 | 6024 | 0.08 | Why? |
Kidney | 1 | 2020 | 3648 | 0.08 | Why? |
Sex Factors | 2 | 2020 | 11014 | 0.08 | Why? |
Environmental Monitoring | 1 | 2018 | 3143 | 0.08 | Why? |
Young Adult | 5 | 2020 | 93724 | 0.07 | Why? |
World Health Organization | 1 | 2018 | 4213 | 0.07 | Why? |
Consensus | 1 | 2020 | 6345 | 0.07 | Why? |
Spain | 2 | 2020 | 15545 | 0.07 | Why? |
Middle Aged | 9 | 2020 | 270681 | 0.07 | Why? |
Models, Biological | 1 | 2021 | 4907 | 0.06 | Why? |
Receptors, Virus | 1 | 2020 | 5659 | 0.06 | Why? |
Interleukin-6 | 1 | 2021 | 7522 | 0.06 | Why? |
Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
Drug Repositioning | 1 | 2021 | 5683 | 0.06 | Why? |
Disease Progression | 1 | 2021 | 13580 | 0.06 | Why? |
Case-Control Studies | 1 | 2020 | 17671 | 0.06 | Why? |
Trichuris | 1 | 2020 | 23 | 0.06 | Why? |
Dutasteride | 1 | 2020 | 22 | 0.06 | Why? |
Finasteride | 1 | 2020 | 29 | 0.06 | Why? |
Models, Theoretical | 1 | 2020 | 6659 | 0.06 | Why? |
ARNTL Transcription Factors | 1 | 2020 | 17 | 0.05 | Why? |
Aged | 6 | 2020 | 215776 | 0.05 | Why? |
Brazil | 1 | 2019 | 12582 | 0.05 | Why? |
Tertiary Care Centers | 1 | 2019 | 8248 | 0.05 | Why? |
Length of Stay | 1 | 2019 | 11042 | 0.05 | Why? |
Exercise | 1 | 2021 | 6771 | 0.05 | Why? |
DNA Repair | 1 | 2020 | 114 | 0.05 | Why? |
Obesity | 1 | 2020 | 7388 | 0.05 | Why? |
Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
Rejuvenation | 1 | 2018 | 41 | 0.05 | Why? |
Anti-Bacterial Agents | 1 | 2021 | 10083 | 0.05 | Why? |
Hypertension | 1 | 2020 | 8895 | 0.05 | Why? |
Esthetics | 1 | 2018 | 136 | 0.04 | Why? |
Prevalence | 1 | 2020 | 25773 | 0.04 | Why? |
Risk Assessment | 2 | 2020 | 25439 | 0.04 | Why? |
Gonadal Steroid Hormones | 1 | 2020 | 328 | 0.04 | Why? |
Administration, Topical | 1 | 2018 | 272 | 0.04 | Why? |
Adolescent | 2 | 2019 | 86841 | 0.04 | Why? |
Masks | 1 | 2018 | 8528 | 0.04 | Why? |
Infant | 1 | 2019 | 30274 | 0.04 | Why? |
Child, Preschool | 1 | 2019 | 36283 | 0.03 | Why? |
Animals | 3 | 2020 | 78931 | 0.03 | Why? |
Melatonin | 1 | 2020 | 578 | 0.03 | Why? |
Aged, 80 and over | 2 | 2020 | 88759 | 0.03 | Why? |
Cross-Sectional Studies | 1 | 2020 | 53120 | 0.03 | Why? |
Observational Studies as Topic | 1 | 2020 | 1887 | 0.03 | Why? |
Sequence Analysis, DNA | 1 | 2020 | 2830 | 0.03 | Why? |
Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
Treatment Outcome | 1 | 2018 | 51732 | 0.03 | Why? |
Retrospective Studies | 2 | 2020 | 105322 | 0.03 | Why? |
Age Distribution | 1 | 2020 | 3567 | 0.03 | Why? |
Child | 1 | 2019 | 70012 | 0.02 | Why? |
Risk | 1 | 2020 | 5288 | 0.02 | Why? |
Sleep | 1 | 2020 | 2695 | 0.02 | Why? |
Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
Prospective Studies | 2 | 2020 | 43301 | 0.02 | Why? |
Longitudinal Studies | 1 | 2020 | 9893 | 0.02 | Why? |
Drug Therapy, Combination | 1 | 2018 | 7268 | 0.02 | Why? |
Intensive Care Units | 2 | 2020 | 29594 | 0.02 | Why? |
T-Lymphocytes | 1 | 2020 | 6670 | 0.02 | Why? |
Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
Public Health | 1 | 2020 | 16359 | 0.01 | Why? |
Wambier's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(202)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(85)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_